MedTrace Logo

Differential Intervention Trial by Standard Therapy Versus Pitavastatin in Patients With Chronic Hemodialysis (DIALYSIS)

NCT00846118 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 905

Last updated 2021-08-30

No results posted yet for this study

Summary

The purpose of this study is to verify whether pitavastatin prevents from cardiovascular events and improves the mortality in chronic hemodialysis patients with hypercholesteremia.

Conditions

Interventions

DRUG

Pitavastatin

1-4mg/day

Sponsors & Collaborators

  • Chieko Hamada

    lead OTHER

Principal Investigators

  • Yasuhiko Tomino, MD,PhD · Professor of Medicine, Department of Nephrology, Juntendo University Graduate School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-01
Primary Completion
2011-01-31
Completion
2014-09-30

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00846118 on ClinicalTrials.gov